Frank X. Leonard - 06 Sep 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Development Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
Issuer symbol
NVCR
Transactions as of
06 Sep 2022
Net transactions value
-$108,741
Form type
4
Filing time
07 Sep 2022, 16:27:43 UTC
Previous filing
06 Sep 2022
Next filing
13 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale $108,741 -1,384 -1.6% $78.57 86,013 06 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard.